Mitobridge

Mitobridge is discovering and developing novel therapies that enhance mitochondrial function. Based on emerging scientific discoveries linking mitochondrial dysfunction to disease pathology, innovative approaches are being developed to treat diseases with high unmet medical needs. The strategy is to establish proof of concept in rare diseases before expanding to more common conditions. Mitobridge has assembled a strong team with expertise in advancing therapies to the clinic. Our scientific founders and advisors include leaders in mitochondrial biology, metabolism, and aging, with experience in translating new discoveries into next-generation drugs. This biology-based approach is being used to explore other significant pathways with potential for major clinical impact.